Forte Biosciences is a clinical-stage biopharmaceutical company focused on dermatology. Forte’s lead product, FB-401, is a topically applied live biotherapeutic for the treatment of inflammatory skin disease developed in collaboration with the National Institutes of Health (“NIH”), and the National Institute of Allergy and Infectious Diseases (“NIAID”).